Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab-Reference-Cited by-同舟云学术

Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab

Published:2023-12 Issue:12 Volume:31 Page:1612-1626
ISSN:1063-4584
Container-title:Osteoarthritis and Cartilage
language:en
Short-container-title:Osteoarthritis and Cartilage

Author:

Carrino John A.,McAlindon Timothy E.,Schnitzer Tom J.,Guermazi Ali^ORCID,Hochberg Marc C.,Conaghan Philip G.,Brown Mark T.,Burr Aimee,Fountaine Robert J.,Pixton Glenn C.,Viktrup Lars^ORCID,Verburg Kenneth M.,West Christine R.

Funder

Pfizer

National Institute for Health and Care Research

Eli Lilly and Company

Leeds Biomedical Research Centre

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology

Reference32 articles.

1. Anti-nerve growth factor in pain management: current evidence;Chang;J Pain Res,2016

2. Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies;Hochberg;Osteoarthr Cartil,2015

3. When is osteonecrosis not osteonecrosis?: adjudication of reported serious adverse joint events in the tanezumab clinical development program;Hochberg;Arthritis Rheumatol,2016

4. Long-term safety and efficacy of subcutaneous tanezumab versus nonsteroidal antiinflammatory drugs for hip or knee osteoarthritis: a randomized trial;Hochberg;Arthritis Rheumatol,2021

5. Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial;Schnitzer;JAMA,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arthrose: Welche Folgen hat Tanezumab für die Gelenke?;Aktuelle Rheumatologie;2024-06

2. Re: Re: Laboratory Safety Evaluation of Bedinvetmab, a Canine Anti-Nerve Growth Factor Monoclonal Antibody, in Dogs;2024

3. Targeting TRP Channels for Pain, Itch and Neurogenic Inflammation;International Journal of Molecular Sciences;2023-12-25